Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2003
07/10/2003WO2003055905A2 Proteins of non typable haemophilus influenzae
07/10/2003WO2003055903A1 Transcription regulatory gene and peptide
07/10/2003WO2003055898A1 Enzymatic redox labelling of nucleic acids
07/10/2003WO2003055529A1 Dna vaccine for periodontal disease
07/10/2003WO2003055507A1 Remedies for anorexia or lifestyle-related diseases and method of screening the same
07/10/2003WO2003055505A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
07/10/2003WO2003055443A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003055302A1 Knockout swine and methods for making the same
07/10/2003WO2003035670A3 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
07/10/2003WO2003033677A3 Dimerized growth factor and materials and methods for producing it
07/10/2003WO2003027298A9 Stem-loop vector system
07/10/2003WO2003024992A3 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
07/10/2003WO2003023360A3 Methods and apparatus for conducting multiple measurements on a sample
07/10/2003WO2003023030A3 Aminopeptidase
07/10/2003WO2003023015A3 Method for expression of small antiviral rna molecules within a cell
07/10/2003WO2003016490A3 Rna silencing suppression
07/10/2003WO2003008636A3 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection
07/10/2003WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors
07/10/2003WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors
07/10/2003WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
07/10/2003WO2003002765A3 Methods for the diagnosis of cancer based on the obcam and ntm genes
07/10/2003WO2003002749A3 Methods for the simultaneous detection of hcv antigens and hcv antibodies
07/10/2003WO2003000861A3 Eukaryotic genes involved in adult lifespan regulation
07/10/2003WO2002092625A3 Moraxella(branhamella) catarrhalis antigens
07/10/2003WO2002092612A3 Nucleic acids that bind to enterotoxin b
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002089728A3 Recombinant rhabdoviruses as live-viral vaccines
07/10/2003WO2002086111A3 Recombinant alpha-amino ester hydrolases and uses thereof
07/10/2003WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
07/10/2003WO2002074956A3 Dopaminergic neuronal survival-promoting factors and uses thereof
07/10/2003WO2002072788A3 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
07/10/2003WO2002068619A3 Bfit (brown fat inducible thioesterase) polypeptides and polynucleotides and their use
07/10/2003WO2002065990A3 A COMPOSITION AND METHOD FOR RECONSTITUTING I$G(K)B KINASE IN YEAST AND METHODS OF USING SAME
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002061435A3 Subunit vaccines with a2 supermotifs
07/10/2003WO2002061125A3 Immobilised aptamers
07/10/2003WO2002061078A3 Streptavidin aptamere
07/10/2003WO2002059326A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
07/10/2003WO2002059278A3 Differentiation of stem cells to pancreatic endocrine cells
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002057310A3 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002046238A3 Rationally designed antibodies
07/10/2003WO2002046229A3 Novel proteins and nucleic acids encoding same
07/10/2003WO2002042463A3 Compositions and methods relating to prostate specific genes and proteins
07/10/2003WO2002042450A8 Sugarcane bacilliform virus promoters derived from isolates isolated from sugarcane cultivars
07/10/2003WO2002040672A3 Compositions and methods relating to breast specific genes and proteins
07/10/2003WO2002040541A3 Transporters and ion channels
07/10/2003WO2002040538A8 Regulation of human nmda receptor
07/10/2003WO2002038764A3 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
07/10/2003WO2002036766A3 Protein-protein complexes and methods of using same
07/10/2003WO2002034946A3 Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof
07/10/2003WO2002032939A3 Secreted proteins and their uses
07/10/2003WO2002029042A3 48120, 23479, and 46689, novel human hydrolases and uses thereof
07/10/2003WO2002028408A9 Compositions and methods for the transport of biologically active agents across cellular barriers
07/10/2003WO2002024896A3 Screening assays for agonists or antagonists of receptor activat or of nf-kb
07/10/2003WO2002022874A8 Oligonucleotides for labeling oligonucleotide probes and proteins
07/10/2003WO2002022835A3 Targeted genetic manipulation using mu bacteriophage cleaved donor complex
07/10/2003WO2002022675A3 Plant genes, the expression of which are altered by pathogen infection
07/10/2003WO2002018581A3 G-protein coupled receptors
07/10/2003WO2002018577A9 48921, a novel human gtp releasing factor and uses therefor
07/10/2003WO2002016596A3 pRNA CHIMERA
07/10/2003WO2002013845A3 Inflammation related g-protein coupled receptor
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003WO2002011672A3 Transgenic mice containing ubiquitin protein ligase e3 gene disruptions
07/10/2003WO2002010750A3 Biosensors, reagents and diagnostic applications of directed evolution
07/10/2003WO2002010335A3 ANTIBODIES SPECIFIC FOR UNGULATE PrP
07/10/2003WO2002004628A3 Method of identifying a binding partner of a gene product
07/10/2003WO2002003791A3 Transgenic mice containing targeted gene disruptions
07/10/2003WO2002003788A3 Transgenic mice containing targeted phosphatase gene disruptions
07/10/2003WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor
07/10/2003WO2001096559A3 Regulatable, catalytically active nucleic acids
07/10/2003WO2001096523A3 Polynucleotides related to colon cancer
07/10/2003WO2001094638A3 Asynchronous primed pcr
07/10/2003WO2001090419A3 Methods for genetic analysis of dna to detect sequence variances
07/10/2003WO2001089550A3 Use of ciliary neurotrophic factor
07/10/2003WO2001089364A9 Hcv variants
07/10/2003WO2001079556A3 Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
07/10/2003WO2001068857A9 18615 and 48003, human ion channels and uses therefor
07/10/2003US20030131386 Stress-induced polynucleotides
07/10/2003US20030131385 Polynucleotide sequences from rice
07/10/2003US20030131384 Generating transgenic plants; controlling tumor protein
07/10/2003US20030131383 Peptides with enhanced stability to protease degradation
07/10/2003US20030131382 Chimera gene coding; transgenic plant
07/10/2003US20030131381 Novel ecdysone receptors and methods for their use
07/10/2003US20030131380 Coffee mannanase
07/10/2003US20030131379 Fatty acid desaturases and mutant sequences thereof
07/10/2003US20030131378 Binding toxin to insects; prevent insect resistance
07/10/2003US20030131377 DNA molecules from maize and methods of use thereof
07/10/2003US20030131376 Nucleic acid sequences encoding cell wall-degrading enzymes and use to engineer resistance to fusarium and other pathogens
07/10/2003US20030131375 Genetic engineering; hybrid plant cell
07/10/2003US20030131374 Pepper gene promoters; drives gene expression in transgenic plants
07/10/2003US20030131373 Materials and methods for the modification of plant lignin content
07/10/2003US20030131372 Methods for generating or increasing revenues from crops
07/10/2003US20030131371 Activation of semen cells of horse
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030131368 KV1.7 potassium channel disruptions, compositions and methods relating thereto
07/10/2003US20030131367 Kv3.3b potassium channel disruptions, compositions and methods related thereto
07/10/2003US20030131365 Genetically engineered animals for use as organ donors